Advertisement
Correspondence and communication| Volume 66, ISSUE 3, P439-440, March 2013

Keloid scars and treatment with Botulinum Toxin Type A: The Belfast experience

Published:October 22, 2012DOI:https://doi.org/10.1016/j.bjps.2012.08.042
      There is no universally accepted treatment regimen for Keloid scars.
      • Leventhal D.
      • Furr M.
      • Reiter D.
      Treatment of keloids and hypertrophic scars. A meta-analysis and review of the literature.
      A few reports in the literature have reported benefits with pressure therapy, intralesional steroid injections, laser therapy, radiation therapy or a last resort of intralesional scar excision.
      • Wolfram D.
      • Tzankov A.
      • Pulzi P.
      • Piza-Katzer H.
      Hypertrophic scars and keloids – a review if their pathophysiology, risk factors and therapeutic management.
      Intralesional injection of Botulinum Toxin Type A in to the treatment resistant keloid is a less famous treatment method that has been successfully reported in the literature.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Leventhal D.
        • Furr M.
        • Reiter D.
        Treatment of keloids and hypertrophic scars. A meta-analysis and review of the literature.
        Arch Fac Plast Surg. 2006; 8: 362-368
        • Wolfram D.
        • Tzankov A.
        • Pulzi P.
        • Piza-Katzer H.
        Hypertrophic scars and keloids – a review if their pathophysiology, risk factors and therapeutic management.
        Dermatol Surg. 2009; 35: 171-181
        • Zhibo X.
        • Miaobo Z.
        Botulinum Toxin Type A affects cell cycle distribution of fibroblasts derived from hypertrophic scar.
        J Plast Reconstr Aesthet Surg. 2008; 61: 1128-1129
        • Zhibo X.
        • Miaobo Z.
        Intralesional Botulinum Toxin Type A injection as a new treatment measure for keloids.
        Plast Reconstr Surg. 2009; 124: e275-e277
        • Uyesugi B.
        • Lippincott B.
        • Dave S.
        Treatment of a painful keloid with Botulinum Toxin Type A.
        Am J Phys Med Rehabil. 2010; 89: 153-155